Ez Platform
Vendor:
First CVE: Mar 12, 2023 · Active for 3 years
3
Total CVEs
More Total CVEs than 64% of tracked products
1.5
Avg CVEs / Year
Higher CVE frequency than 56% of tracked products
6.1
Avg CVSS
Higher Avg CVSS than 24% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Ez Platform over time
Volume of CVEsAvg CVSS Base Score
First CVE
Mar 12, 2023
3 years ago
Most Recent CVE
Mar 6, 2026
140 days ago
CVE Severity & Scoring
Ez Platform3 CVEs
33%
67%
All CVEs352,294 CVEs
45%
40%
11%
LowHigh
Attack Vector
Local0 (0.0%)
Network3 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low2 (66.7%)
High1 (33.3%)
Unknown0 (0.0%)
User Interaction
None3 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High1 (33.3%)
None2 (66.7%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (3 CVEs).
3 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2025-70363HIGH Incorrect access control in the REST API of Ibexa & Ciril GROUP eZ Platform / Ciril Platform 2.x allows unauthenticated attackers to access sensitive data via enumerating object ID | Mar 6, 2026 | 7.5 | 27 | NO | NO |
CVE-2022-48365HIGH An issue was discovered in eZ Platform Ibexa Kernel before 1.3.26. The Company admin role gives excessive privileges. | Mar 12, 2023 | 7.2 | 24 | NO | NO |
An issue was discovered in eZ Platform Ibexa Kernel before 1.3.19. It allows determining account existence via a timing attack. | Mar 12, 2023 | 3.7 | 17 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (3 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (3 CVEs).
Media Mentions
Signals from CVEs in this product scope (3 CVEs).
Top CNAs Publishing CVEs For Ez Platform
Top CWEs
Versions
No cataloged versions.